VUVQPPFLGQMMEE-IWAAJCSBSA-N
C35H28F6N8O4S — CID 162609973
Data last refreshed: (MolForge compound catalog, from PubChem)
About VUVQPPFLGQMMEE-IWAAJCSBSA-N
VUVQPPFLGQMMEE-IWAAJCSBSA-N (PubChem CID 162609973) has the molecular formula C35H28F6N8O4S and a molecular weight of 770.72 g/mol. Its IUPAC name is 2-[9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]-N-[(1S)-2-(3,5-difluorophenyl)-1-[3-[3-(methanesulfonamido)-1-methylindazol-7-yl]-4-oxoquinazolin-2-yl]ethyl]acetamide.
Molecular Properties
| Compound Name | VUVQPPFLGQMMEE-IWAAJCSBSA-N |
|---|---|
| PubChem CID | 162609973 |
| Molecular Formula | C35H28F6N8O4S |
| Molecular Weight | 770.72 g/mol |
| Exact Mass | 770.19 |
| IUPAC Name | 2-[9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]-N-[(1S)-2-(3,5-difluorophenyl)-1-[3-[3-(methanesulfonamido)-1-methylindazol-7-yl]-4-oxoquinazolin-2-yl]ethyl]acetamide |
| SMILES | Cn1nc(NS(C)(=O)=O)c2cccc(-n3c([C@H](Cc4cc(F)cc(F)c4)NC(=O)Cn4nc(C(F)F)c5c4C(F)(F)C4CC54)nc4ccccc4c3=O)c21 |
| InChI | InChI=1S/C35H28F6N8O4S/c1-47-29-20(32(45-47)46-54(2,52)53)7-5-9-25(29)49-33(43-23-8-4-3-6-19(23)34(49)51)24(12-16-10-17(36)13-18(37)11-16)42-26(50)15-48-30-27(28(44-48)31(38)39)21-14-22(21)35(30,40)41/h3-11,13,21-22,24,31H,12,14-15H2,1-2H3,(H,42,50)(H,45,46)/t21?,22?,24-/m0/s1 |
| InChIKey | VUVQPPFLGQMMEE-IWAAJCSBSA-N |
| XLogP | 5.37 |
| TPSA | 145.80 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 54 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 770.72 |
| LogP ≤ 5 | 5.37 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 162609973 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.